GridAI Technologies (GRDX) Income from Discontinued Operations (2024 - 2025)
GridAI Technologies' (GRDX) quarterly Income from Discontinued Operations came in at $504510.0 in Q4 2025, up 214.78% on a YoY basis from $160275.1 in Q4 2024, and up 377.27% quarter-over-quarter from -$181953.0 in Q3 2025.
Powered by 
Analysis
GridAI Technologies (GRDX) Income from Discontinued Operations (2024 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has reported Income from Discontinued Operations for 2 consecutive years, with $504510.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Income from Discontinued Operations rose 214.78% year-over-year to $504510.0; the trailing twelve-month figure through Dec 2025 stood at -$440338.0 (changed N/A YoY), and the FY2025 full-year result was -$312298.0, up 87.2% from the prior year.
- Income from Discontinued Operations grew to $504510.0 in Q4 2025 per GRDX's latest filing, from -$181953.0 in the prior quarter.
- Across five years, Income from Discontinued Operations topped out at $504510.0 in Q4 2025 and bottomed at -$1.1 million in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 504,510.00 |
| Sep 30, 2025 | -181,953.00 |
| Jun 30, 2025 | -323,340.00 |
| Dec 31, 2024 | -439,555.00 |
| Sep 30, 2024 | -685,719.00 |
| Jun 30, 2024 | -1.12 Mn |